CPT 0307U Pathology/Laboratory
Subsequent gene analysis for minimum residual disease in cancer, Cost
Body System: General
Medicare Facility Rate
$794
CMS PFS CY2026
Medicare Non-Facility Rate
$794
Office/clinic setting
Frequently Asked Questions
How much does Subsequent gene analysis for minimum residual disease in cancer, cost?
The Medicare facility rate is $794. Commercial insurance typically pays 150-250% of Medicare rates (varies).
How much does Subsequent gene analysis for minimum residual disease in cancer, cost without insurance?
Without insurance, you may pay the hospital's chargemaster rate, which is often 300-500% of Medicare. Ask about cash-pay discounts — many facilities offer 20-40% off for self-pay patients. The Medicare baseline for this procedure is $794.